Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"confidence"

Slides: 1–12 of 124
Add to tray Remove from tray

Outline of Material

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: outline | comparative effectiveness research | key considerations | study size planning
Add to tray Remove from tray

Considerations for Observational Comparative Effectiveness Research Study Size Planning

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: observational comparative effectiveness research | study size
Add to tray Remove from tray

Summary Checklist (1 of 2)

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: summary checklist | study size | statistical methods
Add to tray Remove from tray

Summary Checklist (2 of 2)

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: summary checklist | study size | statistical methods
Add to tray Remove from tray

Rating the Strength of Evidence From the CER

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: EPC GRADE | PICOTS | strength of evidence | comparative effectiveness review
Add to tray Remove from tray

Rating the Strength of Evidence From the CER

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: EPC | Evidence-based Practice Center | GRADE | PICOTS | applicability | comparative effectiveness review | strength of evidence
Add to tray Remove from tray

Rating the Strength of Evidence From the CER

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: strength of evidence | CER | confidence | research
Add to tray Remove from tray

Background: Using Serological Tests To Diagnose Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | diagnosis | patient history | physical examination | pain pattern | serological tests | antinuclear antibody | rheumatoid factor | cyclic-citrullinated peptide
Add to tray Remove from tray

Rating the Strength of Evidence From the Comparative Effectiveness Review

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: comparative effectiveness review | strength of evidence | evidence grade | risk of bias | consistency | directness | precision | Quality Assessment of Diagnostic Accuracy Studies | QUADAS
Applicability of a Body of Evidence. Applicability of a body of evidence is not the same as applicability of individual studies. A collection of studies may provide broad applicable evidence even if individual studies do not. Consistency of study results across different populations and settings increases confidence in the applicability of the results. Applicability depends on context and cannot be assessed with a simple rating scale. There are no empiric data validating any scoring system for applicability.
Add to tray Remove from tray

Applicability of a Body of Evidence

Presentation: Assessing Applicability
Keywords: applicability | body of evidence | population
This slide presents two scenarios. In scenario 1, the studies are all clustered around higher age; whereas, in scenario 2, the studies are all dispersed across the continuum of age. Because the populations seen in actual clinical practice are mostly in the low-to-moderate age range, scenario 2 has greater applicability.
Add to tray Remove from tray

Which Series of Studies Has an Applicability Issue?

Presentation: Assessing Applicability
Keywords: applicability | heterogeneity
Strength of Evidence. Why should grading of the strength of evidence and assessment of applicability be carried out separately? A. Strength of evidence grading and applicability assessment are essentially the same. B. Studies using strong methods can show that an intervention is superior to a control therapy in a study population, but it may or may not work in actual practice. C. Strength of evidence grading is primarily associated with assessing the external validity, whereas applicability assessment is concerned with internal validity.
Add to tray Remove from tray

Strength of Evidence

Presentation: Assessing Applicability Quiz
Pages: [1] 2 3 4 5 6 7 8 9 10 11 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364